Cargando…

Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice

OBJECTIVE: To investigate the utility of serum squamous cell carcinoma antigen (SCC-Ag) levels upon the diagnosis of recurrent cervical cancer for decision making in patient management. METHODS: Clinical records from 167 cervical cancer patients who developed recurrence between April 1996 and Septem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimura, Kotaro, Mabuchi, Seiji, Yokoi, Takeshi, Sasano, Tomoyuki, Sawada, Kenjirou, Hamasaki, Toshimitsu, Kimura, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805912/ https://www.ncbi.nlm.nih.gov/pubmed/24167667 http://dx.doi.org/10.3802/jgo.2013.24.4.321

Ejemplares similares

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
por: Kawano, Mahiru, et al.
Publicado: (2015)

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer
por: Kuroda, Hiromasa, et al.
Publicado: (2018)

Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review
por: Kozasa, Katsumi, et al.
Publicado: (2017)

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer
por: Shimura, Kotaro, et al.
Publicado: (2021)

Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models
por: Kozasa, Katsumi, et al.
Publicado: (2019)

Prognostic significance of the pretreatment prognostic nutritional index in patients with epithelial ovarian cancer
por: Komura, Naoko, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies
por: Mabuchi, Seiji, et al.
Publicado: (2020)

Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma
por: Yokoi, Eriko, et al.
Publicado: (2017)

Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2011)

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
por: Takahashi, Ryoko, et al.
Publicado: (2016)

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy
por: Yoshimura, Akihiko, et al.
Publicado: (2018)

Premetastatic niche and tumor-related leukocytosis: a close relationship that cannot be ignored in uterine cancer patients
por: Mabuchi, Seiji, et al.
Publicado: (2018)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2023)

Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study
por: Mabuchi, Seiji, et al.
Publicado: (2023)

Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
por: Matsuo, Koji, et al.
Publicado: (2015)

Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
por: Mabuchi, Seiji, et al.
Publicado: (2017)

Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
por: Mabuchi, Seiji, et al.
Publicado: (2016)

CS-03 LARGE CYSTIC INTRADURAL SCHWANNOMA IN CERVICAL REGION: A CASE REPORT
por: Takeshima, Yuki, et al.
Publicado: (2019)

CS-07 A CYSTIC LONG-SEGMENT CERVICAL SCHWANNOMA: A CASE REPORT
por: Takeshima, Yuki, et al.
Publicado: (2019)

Efficacies of uterine artery embolization for symptomatic uterine fibroids using gelatin sponge: a single-center experience and literature review
por: Toda, Aska, et al.
Publicado: (2016)

A 3-year follow-up study of radiotherapy using computed tomography–based image-guided brachytherapy for cervical cancer
por: Kawashima, Atsushi, et al.
Publicado: (2019)

Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
por: Matsuo, K, et al.
Publicado: (2013)

Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors
por: Fujiwara, Masateru, et al.
Publicado: (2015)

Dose–volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy
por: Isohashi, Fumiaki, et al.
Publicado: (2016)

Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorder
por: Arano, Ichiro, et al.
Publicado: (2010)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma
por: Kinose, Yasuto, et al.
Publicado: (2015)

Squamous cell carcinoma antigen in cervical cancer and beyond
por: Kim, Byoung-Gie
Publicado: (2013)

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
por: Kobayashi, Masaki, et al.
Publicado: (2020)

The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients
por: Ryu, Hyun Kyung, et al.
Publicado: (2015)

Sample size determination in clinical trials with multiple endpoints
por: Sozu, Takashi, et al.
Publicado: (2015)

Corrigendum: A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints (10.1093/biostatistics/kxs057)
por: Sugimoto, Tomoyuki, et al.
Publicado: (2016)

Estimation of the total rectal dose of radical external beam and intracavitary radiotherapy for uterine cervical cancer using the deformable image registration method
por: Hayashi, Kazuhiko, et al.
Publicado: (2015)

Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy
por: Kuruma, Airi, et al.
Publicado: (2022)

Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer
por: Huang, Xiao-Dan, et al.
Publicado: (2023)

Pure Primary Ovarian Squamous Cell Carcinoma Perforating the Rectum
por: Mimura, Kazuya, et al.
Publicado: (2017)

Prognostic Value of Different Patterns of Squamous Cell Carcinoma Antigen Level for the Recurrent Cervical Cancer
por: Jeong, Bae Kwon, et al.
Publicado: (2013)

Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy
por: Mabuchi, Seiji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_srsp316qf54lh9rfqi0e16hjo6